STOCK TITAN

[SCHEDULE 13G/A] BRUKER CORP SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

FMR LLC and Abigail P. Johnson report beneficial ownership of 17,082,319.90 shares of Bruker Corporation common stock, representing 11.0% of the outstanding class. The filing, a Schedule 13G/A, indicates these shares are held in the ordinary course of business and not for the purpose of changing control. The report shows FMR LLC with 13,832,390.78 shares of sole voting power and 17,082,319.90 shares of sole dispositive power; Abigail P. Johnson is reported with sole dispositive power over 17,082,319.90 shares and no voting power. The filing references an event date of 09/30/2025 and is signed on 10/06/2025. An Exhibit 99 agreement is attached per the document.

FMR LLC e Abigail P. Johnson riportano la proprietà beneficiante di 17.082.319,90 azioni comuni della Bruker Corporation, che rappresentano 11,0% delle azioni in circolazione. Il deposito, una Schedule 13G/A, indica che queste azioni sono detenute nel normale svolgimento dell'attività e non per cambiare il controllo. Il rapporto mostra FMR LLC con 13.832.390,78 azioni di potere di voto esclusivo e 17.082.319,90 azioni di potere dispositive esclusivo; Abigail P. Johnson è riportata con potere dispositivo esclusivo su 17.082.319,90 azioni e nessun potere di voto. Il deposito fa riferimento a una data evento 09/30/2025 ed è firmato il 10/06/2025. Un accordo Exhibit 99 è allegato al documento.

FMR LLC y Abigail P. Johnson informan de la propiedad beneficiosa de 17,082,319.90 acciones ordinarias de Bruker Corporation, que representan 11,0% de las acciones en circulación. La presentación, un Schedule 13G/A, indica que estas acciones se mantienen en el curso normal de los negocios y no con el propósito de cambiar el control. El informe muestra FMR LLC con 13,832,390.78 acciones de poder de voto exclusivo y 17,082,319.90 acciones de poder dispositvo exclusivo; Abigail P. Johnson se reporta con poder dispositivo exclusivo sobre 17,082,319.90 acciones y sin poder de voto. La presentación hace referencia a una fecha de evento 09/30/2025 y está firmada el 10/06/2025. Un acuerdo Exhibit 99 está adjunto al documento.

FMR LLC 및 Abigail P. Johnson은 Bruker Corporation 보통주 17,082,319.90주에 대한 실질적 소유를 보고하며, 이는 11.0%의 미발행 주식 대비 지분이다. 제출서는 Schedule 13G/A로, 이 주식이 일반적 업무상 보유되며 지배권 변경을 위한 것이 아님을 나타낸다. 보고서는 FMR LLC가 단독 의결권 13,832,390.78주와 단독 처분권 17,082,319.90주를 보유하고 있으며; Abigail P. Johnson은 단독 처분권이 17,082,319.90주이고 의결권은 없다. 제출서는 사건일자를 2025-09-30로 언급하며 2025-10-06에 서명되었다. 문서는 Exhibit 99 합의서를 첨부하고 있다.

FMR LLC et Abigail P. Johnson déclarent une propriété bénéficiaire de 17 082 319,90 actions ordinaires de Bruker Corporation, représentant 11,0% des actions en circulation. Le dépôt, un Schedule 13G/A, indique que ces actions sont détenues dans le cours normal des affaires et non dans le but de changer le contrôle. Le rapport montre FMR LLC avec 13 832 390,78 actions de pouvoir de vote exclusif et 17 082 319,90 actions de pouvoir discrétionnaire exclusif ; Abigail P. Johnson est signalée avec le pouvoir discrétionnaire exclusif sur 17 082 319,90 actions et aucun pouvoir de vote. Le dépôt fait référence à une date d’événement 09/30/2025 et est signé le 10/06/2025. Un accord Exhibit 99 est joint au document.

FMR LLC und Abigail P. Johnson melden eine wirtschaftliche Eigentümerschaft an 17.082.319,90 Aktien der Bruker Corporation Stammaktien, was 11,0% der ausstehenden Klasse entspricht. Die Einreichung, eine Schedule 13G/A, gibt an, dass diese Aktien im gewöhnlichen Geschäftsverlauf gehalten werden und nicht zum Zwecke der Änderung der Kontrolle. Der Bericht zeigt FMR LLC mit 13.832.390,78 Aktien an allein stimmrechtsbefugter Anteil und 17.082.319,90 Aktien an allein dispositivem Anteil; Abigail P. Johnson wird mit allein dispositivem Anteil über 17.082.319,90 Aktien und ohne Stimmrecht angegeben. Das Formular verweist auf ein Ereignisdatum 09/30/2025 und ist am 10/06/2025 unterzeichnet. Ein Exhibit 99-Vereinbarung ist dem Dokument beigefügt.

شركة FMR LLC وAbigail P. Johnson يبلغان بملكية مستفاد منها لعدد 17,082,319.90 سهماً من أسهم-bruker الشركة، تمثل 11.0% من الأسهم القائمة. الإيداع، Schedule 13G/A، يشير إلى أن هذه الأسهم مملوكة في مسار العمل العادي وليست بغرض تغيير السيطرة. يُظهر التقرير FMR LLC بثبوت حق التصويت الوحيد لــ13,832,390.78 سهماً و< b>17,082,319.90 سهماً من السلطة الوحيدة لتحديد التصرف؛ Abigail P. Johnson تُبلغ عنها بسلطة اتخاذ القرار الوحيدة على 17,082,319.90 سهمًا وبدون سلطة تصويت. يسند الإيداع تاريخ حدث 09/30/2025 وموقع التوقيع في 10/06/2025. مرفق اتفاق Exhibit 99 مع المستند.

FMR LLC 与 Abigail P. Johnson 报告对 Bruker Corporation 普通股的实益所有权,共 17,082,319.90 股,代表已发行类别的 11.0% 该备案为 Schedule 13G/A,表明这些股份是在日常业务中持有,并非为改变控制权而持有。报告显示 FMR LLC 拥有 13,832,390.78 股单独表决权和 17,082,319.90 股单独处置权;Abigail P. Johnson 被报告为对 17,082,319.90 股拥有单独处置权且没有表决权。备案提及事件日期 2025-09-30,并于 2025-10-06 签署。文档附有 Exhibit 99 协议。

Positive
  • Clear reporting of material stake: the filing discloses an 11.0% ownership position (17,082,319.90 shares)
  • Passive intent stated: certification that holdings are in the ordinary course of business and not to change control
  • Documented voting/dispositive powers: FMR LLC reports specific sole voting and dispositive power figures
Negative
  • No disclosure of underlying accounts or funds that account for the shares beyond general statement that others may have dividend/proceeds rights
  • Potential governance concentration: a single reporting group holds a material 11.0% stake which could affect shareholder votes if strategy changes
  • Limited detail on Exhibit 99: the referenced agreement is not summarized in the filing text

Insights

Large passive stake: 11.0% ownership signals material institutional exposure.

Holding 17,082,319.90 shares and representing 11.0% of the class makes this a material position that could influence liquidity and shareholder voting outcomes simply by its size. The filing states the position is held in the ordinary course of business and not to change control, which aligns with a passive investment posture.

This position includes clear voting and dispositive power allocations: FMR LLC reports 13,832,390.78 shares of sole voting power and 17,082,319.90 shares of sole dispositive power. Investors may watch any subsequent amendments, changes in voting/dispositive power, or related Exhibit 99 details over the next 3–12 months for signs of strategy changes.

Significant individual and parent reporting with explicit certifications and POAs.

The filing lists both FMR LLC and Abigail P. Johnson as reporting persons, with powers documented via powers of attorney incorporated by reference to earlier exhibits. The certification asserts the securities were not acquired to influence control and were acquired in the ordinary course of business.

Key items to monitor include the referenced Exhibit 99 agreement and any future Schedule 13D/A or 13G amendments that would change the stated intent or ownership percentages; relevant updates could appear within the next reporting cycle.

FMR LLC e Abigail P. Johnson riportano la proprietà beneficiante di 17.082.319,90 azioni comuni della Bruker Corporation, che rappresentano 11,0% delle azioni in circolazione. Il deposito, una Schedule 13G/A, indica che queste azioni sono detenute nel normale svolgimento dell'attività e non per cambiare il controllo. Il rapporto mostra FMR LLC con 13.832.390,78 azioni di potere di voto esclusivo e 17.082.319,90 azioni di potere dispositive esclusivo; Abigail P. Johnson è riportata con potere dispositivo esclusivo su 17.082.319,90 azioni e nessun potere di voto. Il deposito fa riferimento a una data evento 09/30/2025 ed è firmato il 10/06/2025. Un accordo Exhibit 99 è allegato al documento.

FMR LLC y Abigail P. Johnson informan de la propiedad beneficiosa de 17,082,319.90 acciones ordinarias de Bruker Corporation, que representan 11,0% de las acciones en circulación. La presentación, un Schedule 13G/A, indica que estas acciones se mantienen en el curso normal de los negocios y no con el propósito de cambiar el control. El informe muestra FMR LLC con 13,832,390.78 acciones de poder de voto exclusivo y 17,082,319.90 acciones de poder dispositvo exclusivo; Abigail P. Johnson se reporta con poder dispositivo exclusivo sobre 17,082,319.90 acciones y sin poder de voto. La presentación hace referencia a una fecha de evento 09/30/2025 y está firmada el 10/06/2025. Un acuerdo Exhibit 99 está adjunto al documento.

FMR LLC 및 Abigail P. Johnson은 Bruker Corporation 보통주 17,082,319.90주에 대한 실질적 소유를 보고하며, 이는 11.0%의 미발행 주식 대비 지분이다. 제출서는 Schedule 13G/A로, 이 주식이 일반적 업무상 보유되며 지배권 변경을 위한 것이 아님을 나타낸다. 보고서는 FMR LLC가 단독 의결권 13,832,390.78주와 단독 처분권 17,082,319.90주를 보유하고 있으며; Abigail P. Johnson은 단독 처분권이 17,082,319.90주이고 의결권은 없다. 제출서는 사건일자를 2025-09-30로 언급하며 2025-10-06에 서명되었다. 문서는 Exhibit 99 합의서를 첨부하고 있다.

FMR LLC et Abigail P. Johnson déclarent une propriété bénéficiaire de 17 082 319,90 actions ordinaires de Bruker Corporation, représentant 11,0% des actions en circulation. Le dépôt, un Schedule 13G/A, indique que ces actions sont détenues dans le cours normal des affaires et non dans le but de changer le contrôle. Le rapport montre FMR LLC avec 13 832 390,78 actions de pouvoir de vote exclusif et 17 082 319,90 actions de pouvoir discrétionnaire exclusif ; Abigail P. Johnson est signalée avec le pouvoir discrétionnaire exclusif sur 17 082 319,90 actions et aucun pouvoir de vote. Le dépôt fait référence à une date d’événement 09/30/2025 et est signé le 10/06/2025. Un accord Exhibit 99 est joint au document.

FMR LLC und Abigail P. Johnson melden eine wirtschaftliche Eigentümerschaft an 17.082.319,90 Aktien der Bruker Corporation Stammaktien, was 11,0% der ausstehenden Klasse entspricht. Die Einreichung, eine Schedule 13G/A, gibt an, dass diese Aktien im gewöhnlichen Geschäftsverlauf gehalten werden und nicht zum Zwecke der Änderung der Kontrolle. Der Bericht zeigt FMR LLC mit 13.832.390,78 Aktien an allein stimmrechtsbefugter Anteil und 17.082.319,90 Aktien an allein dispositivem Anteil; Abigail P. Johnson wird mit allein dispositivem Anteil über 17.082.319,90 Aktien und ohne Stimmrecht angegeben. Das Formular verweist auf ein Ereignisdatum 09/30/2025 und ist am 10/06/2025 unterzeichnet. Ein Exhibit 99-Vereinbarung ist dem Dokument beigefügt.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



FMR LLC
Signature:Stephanie J. Brown
Name/Title:Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:10/06/2025
Abigail P. Johnson
Signature:Stephanie J. Brown
Name/Title:Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson**
Date:10/06/2025

Comments accompanying signature: * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.
Exhibit Information

Please see Exhibit 99 for 13d-1(k) (1) agreement.

FAQ

What stake does FMR LLC report in BRKR?

FMR LLC reports beneficial ownership of 17,082,319.90 shares, equal to 11.0% of the common stock class.

Does Abigail P. Johnson hold voting power in BRKR?

The filing shows Abigail P. Johnson has 0 sole voting power and 17,082,319.90 sole dispositive power over the shares.

Was the BRKR position acquired to change control?

The certifying statement declares the securities were acquired and are held in the ordinary course of business and not to change or influence control.

When is the event date reported for this Schedule 13G/A?

The filing lists the date of the event requiring this statement as 09/30/2025 and is signed on 10/06/2025.

Where can I find details of the subsidiary/group agreement?

The filing references an Exhibit 99 for the 13d-1(k)(1) agreement; the filing text does not summarize its contents.
Bruker Corp

NASDAQ:BRKR

BRKR Rankings

BRKR Latest News

BRKR Latest SEC Filings

BRKR Stock Data

5.35B
103.16M
31.98%
84.57%
5.51%
Medical Devices
Laboratory Analytical Instruments
Link
United States
BILLERICA